141 related articles for article (PubMed ID: 25550078)
1. Factor VIII Antigen, Activity, and Mutations in Hemophilia A.
Nair PS; Shetty S; Ghosh K
Clin Appl Thromb Hemost; 2016 May; 22(4):381-5. PubMed ID: 25550078
[TBL] [Abstract][Full Text] [Related]
2. Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: detection of 26 novel mutations and correlation with FVIII inhibitor development.
Repessé Y; Slaoui M; Ferrandiz D; Gautier P; Costa C; Costa JM; Lavergne JM; Borel-Derlon A
J Thromb Haemost; 2007 Jul; 5(7):1469-76. PubMed ID: 17445092
[TBL] [Abstract][Full Text] [Related]
3. The molecular basis for cross-reacting material-positive hemophilia A due to missense mutations within the A2-domain of factor VIII.
Amano K; Sarkar R; Pemberton S; Kemball-Cook G; Kazazian HH; Kaufman RJ
Blood; 1998 Jan; 91(2):538-48. PubMed ID: 9427707
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of mutations in CRM-positive and CRM-reduced hemophilia A.
McGinniss MJ; Kazazian HH; Hoyer LW; Bi L; Inaba H; Antonarakis SE
Genomics; 1993 Feb; 15(2):392-8. PubMed ID: 8449505
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, biological phenotype and genotype in moderate/mild hemophilia A with discrepancy between one-stage and chromogenic factor VIII activity.
Trossaërt M; Boisseau P; Quemener A; Sigaud M; Fouassier M; Ternisien C; Lefrançois-Bettembourg A; Tesson C; Thomas C; Bezieau S
J Thromb Haemost; 2011 Mar; 9(3):524-30. PubMed ID: 21166991
[TBL] [Abstract][Full Text] [Related]
6. [Molecular analysis of a patient with hemophilia A caused by FVIII His99Arg mutation].
Qin HH; Wang XF; Ding QL; Lu YL; Dai J; Xi XD; Wang HL
Zhonghua Xue Ye Xue Za Zhi; 2011 Sep; 32(9):587-91. PubMed ID: 22338150
[TBL] [Abstract][Full Text] [Related]
7. Factor VIII C2 domain missense mutations exhibit defective trafficking of biologically functional proteins.
Pipe SW; Kaufman RJ
J Biol Chem; 1996 Oct; 271(41):25671-6. PubMed ID: 8810344
[TBL] [Abstract][Full Text] [Related]
8. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
[TBL] [Abstract][Full Text] [Related]
9. Factor VIII gene analysis in Japanese CRM-positive and CRM-reduced haemophilia A patients by single-strand conformation polymorphism.
Morichika S; Shima M; Kamisue S; Tanaka I; Imanaka Y; Suzuki H; Shibata H; Pemberton S; Gale K; McVey J; Tuddenham EG; Yoshioka A
Br J Haematol; 1997 Sep; 98(4):901-6. PubMed ID: 9326186
[TBL] [Abstract][Full Text] [Related]
10. Most factor VIII B domain missense mutations are unlikely to be causative mutations for severe hemophilia A: implications for genotyping.
Ogata K; Selvaraj SR; Miao HZ; Pipe SW
J Thromb Haemost; 2011 Jun; 9(6):1183-90. PubMed ID: 21645226
[TBL] [Abstract][Full Text] [Related]
11. Thirty-four novel mutations detected in factor VIII gene by multiplex CSGE: modeling of 13 novel amino acid substitutions.
Habart D; Kalabova D; Novotny M; Vorlova Z
J Thromb Haemost; 2003 Apr; 1(4):773-81. PubMed ID: 12871415
[TBL] [Abstract][Full Text] [Related]
12. Female hemophilia A heterozygous for a de novo frameshift and a novel missense mutation of factor VIII.
Cai XH; Wang XF; Dai J; Fang Y; Ding QL; Xie F; Wang HL
J Thromb Haemost; 2006 Sep; 4(9):1969-74. PubMed ID: 16805874
[TBL] [Abstract][Full Text] [Related]
13. A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor.
Jacquemin M; Lavend'homme R; Benhida A; Vanzieleghem B; d'Oiron R; Lavergne JM; Brackmann HH; Schwaab R; VandenDriessche T; Chuah MK; Hoylaerts M; Gilles JG; Peerlinck K; Vermylen J; Saint-Remy JM
Blood; 2000 Aug; 96(3):958-65. PubMed ID: 10910910
[TBL] [Abstract][Full Text] [Related]
14. Factor VIII Ise (R2159C) in a patient with mild hemophilia A, an abnormal factor VIII with retention of function but modification of C2 epitopes.
Suzuki H; Shima M; Arai M; Kagawa K; Fukutake K; Kamisue S; Nakai H; Morichika S; Tanaka I; Inoue M; Gale K; Tuddenham EG; Yoshioka A
Thromb Haemost; 1997 May; 77(5):862-7. PubMed ID: 9184393
[TBL] [Abstract][Full Text] [Related]
15. Stable recombinant expression and characterization of the two haemophilic factor VIII variants C329S (CRM(-)) and G1948D (CRM(r)).
David D; Saenko EL; Santos IM; Johnson DJ; Tuddenham EG; McVey JH; Kemball-Cook G
Br J Haematol; 2001 Jun; 113(3):604-15. PubMed ID: 11380445
[TBL] [Abstract][Full Text] [Related]
16. Expression studies of mutant factor VIII alleles with premature termination codons with regard to inhibitor formation.
Zimmermann MA; Oldenburg J; Müller CR; Rost S
Haemophilia; 2014 May; 20(3):e215-21. PubMed ID: 24602271
[TBL] [Abstract][Full Text] [Related]
17. Development of an FVIII Inhibitor in a Mild Hemophilia Patient with a Phe595Cys Mutation.
Yamanouchi J; Tokumoto D; Ikeda Y; Maruta M; Kaneko M; Hato T; Yasukawa M
Intern Med; 2018 Nov; 57(21):3179-3182. PubMed ID: 29877292
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of an in vitro cellular expression model for haemophilia A carrier diagnosis: illustration with five novel mutations in the F8 gene in women with isolated factor VIII:C deficiency.
Roualdes O; Nougier C; Fretigny M; Talagrand E; Durand B; Negrier C; Vinciguerra C
Haemophilia; 2015 May; 21(3):e202-e209. PubMed ID: 25708597
[TBL] [Abstract][Full Text] [Related]
19. [Molecular genetics of hemophilia A].
De Brasi CD; Slavutsky IR; Larripa IB
Medicina (B Aires); 1996; 56(5 Pt 1):509-17. PubMed ID: 9239887
[TBL] [Abstract][Full Text] [Related]
20. Missense mutations near the N-glycosylation site of the A2 domain lead to various intracellular trafficking defects in coagulation factor VIII.
Wei W; Zheng C; Zhu M; Zhu X; Yang R; Misra S; Zhang B
Sci Rep; 2017 Mar; 7():45033. PubMed ID: 28327546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
